Mlig455_037784 {REF} {Length: 3338} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=212.5]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=105.3]; Protein kinase domain [PF00069.27, score=81.2]; Receptor family ligand binding region [PF01094.30, score=28.2]; Heme NO binding associated [PF07701.16, score=19.3]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [RH, Score=603, Expect=0.0]; ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [RH, Score=580, Expect=0.0]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [RH, Score=608, Expect=0.0]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [RH, Score=593, Expect=0.0]} {Dmel: FBgn0085386, CG34357, [RH, Score=645, Expect=0.0]} {Celegans: WBGene00001545, gcy-20, Receptor-type guanylate cyclase gcy-20, [RH, Score=429, Expect=6e-132]} {Smed: dd_Smed_v6_33097_0_1, dd_Smed_v6_33097_0_1, [Score=661, Expect=0.0]} {RNA1310_61306}

Mlig455_037679 {REF} {Length: 872} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=146.2]; Heme NO binding associated [PF07701.16, score=21.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=306, Expect=7e-96]; ENSG00000132518, GUCY2D, guanylate cyclase 2D, retinal, [Score=291, Expect=1e-90]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=308, Expect=7e-97]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=306, Expect=3e-96]} {Dmel: FBgn0085386, CG34357, [Score=298, Expect=7e-92]} {Celegans: WBGene00001545, gcy-20, Receptor-type guanylate cyclase gcy-20, [Score=238, Expect=2e-71]} {Smed: dd_Smed_v6_12305_0_1, dd_Smed_v6_12305_0_1, [Score=250, Expect=1e-75]} {RNA1310_61306} {SMEDTYPE: Muscle [dd_Smed_v6_12305_0_1, natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) (NPR1)]} {SMEDTYPE: Xins [raj_facs_types]} {SMEDTYPE: Asexual_biased [CUFF.653638.0]}